Long COVID Dysautonomia and the Genetics of the Autonomic Nervous System
Introduction: Understanding Long COVID Dysautonomia
Long COVID dysautonomia describes a group of symptoms that arise when the autonomic nervous system does not work as it should after a SARS-CoV-2 infection. Many people notice a racing heart when they stand, dizziness, lightheadedness, fatigue that worsens when upright, or trouble tolerating exercise. These experiences can be confusing and exhausting, especially when routine tests come back looking normal.
Dysautonomia is among the most common presentations of Long COVID. It covers several conditions, including postural orthostatic tachycardia syndrome, orthostatic hypotension and vagal dysfunction. Researchers are increasingly interested in why some people develop these autonomic problems after infection while others do not. One area under study is genetics. Research suggests that variation in certain genes may shape how the body produces, recycles and responds to the chemical messengers that keep heart rate and blood pressure steady.
This article explains how the autonomic system works, which genes studies have explored in relation to post-COVID dysautonomia, and what this emerging research may mean for you.
How the Mechanism Works
The autonomic nervous system runs the body's automatic functions. It adjusts heart rate, blood vessel tone, digestion, sweating and fluid balance without conscious effort. It has two main branches: the sympathetic system, often called the "fight or flight" side, and the parasympathetic system, which supports rest and recovery. Healthy function depends on a careful balance between the two.
When you stand up, gravity pulls blood toward your legs. Within seconds, your sympathetic nervous system releases norepinephrine, which tightens blood vessels and nudges heart rate upward so that blood keeps reaching the brain. Several steps must work together for this to happen smoothly:
- Making norepinephrine. Sympathetic neurons convert dopamine into norepinephrine.
- Releasing and limiting it. Feedback receptors on nerve endings help control how much norepinephrine is released.
- Recycling it. A transporter clears norepinephrine from the space between nerve cells so that signals stay precise.
- Responding to it. Receptors on blood vessels and other tissues translate the signal into action, such as vasoconstriction.
- Maintaining blood volume. Hormones that regulate water balance help ensure there is enough fluid in circulation.
In Long COVID, researchers have proposed several ways this system might be disrupted. These include autoimmune activity directed at autonomic receptors, changes in gut signalling that feed into nervous system tone, and altered fluid regulation. Genetic variation at any of these steps could, in theory, influence how resilient a person's autonomic system is under stress.
Relevant Genes and Variants
The genes below belong mainly to the autonomic nervous system cluster in the ChronicDNA dataset. Research in this area is still developing, so these findings should be seen as early clues rather than firm answers.
ADRB2: The Beta-2 Adrenergic Receptor
ADRB2 encodes the beta-2 adrenergic receptor, which mediates smooth muscle relaxation, bronchodilation and metabolic effects. Notably, autoantibodies against this receptor have been identified in people with Long COVID, and research suggests they may contribute to autonomic symptoms, including POTS and exercise intolerance. The variant rs1042713 is one of the commonly studied positions in this gene.
ADRA2A: The Sympathetic "Brake"
ADRA2A encodes the alpha-2A adrenergic receptor, a presynaptic autoreceptor that inhibits norepinephrine release and also mediates peripheral vasoconstriction. Because it acts as a feedback brake on sympathetic activity, studies have explored whether variants such as rs1800544 may influence sympathetic nerve regulation and autonomic balance in Long COVID POTS.
ADRA1A: Blood Vessel Tightening
ADRA1A encodes the alpha-1A adrenergic receptor, which drives sympathetic vasoconstriction in peripheral blood vessels. Alpha-1 adrenergic vasoconstriction is thought to be impaired in POTS. Research suggests that ADRA1A variants, including rs2322333, may affect vascular responses and how well blood pressure is maintained when standing.
DBH: Making Norepinephrine
DBH encodes dopamine beta-hydroxylase, the enzyme that converts dopamine into norepinephrine in sympathetic neurons and adrenal cells. Variants such as rs1611115 and rs6271 may affect norepinephrine production and sympathovagal balance. Studies have explored their possible role in susceptibility to orthostatic intolerance and POTS after COVID-19.
SLC6A2: Recycling Norepinephrine
SLC6A2 encodes the norepinephrine transporter, which recycles norepinephrine at sympathetic synapses. When this transporter does not work well, norepinephrine may linger and signalling can become less precise. An SLC6A2 variant known as Ala457Pro has been associated with orthostatic intolerance, a key feature of POTS. Consumer DNA tests commonly report other positions in this gene, such as rs2242446 and rs36019.
AVP: Fluid Balance and Stress Signalling
AVP encodes arginine vasopressin, also known as antidiuretic hormone. It regulates water reabsorption in the kidney and modulates the stress response. Since blood volume is central to tolerating an upright posture, researchers have suggested that vasopressin dysregulation may contribute to POTS-like symptoms. Variants studied include rs2282018 and rs3759129.
FFAR3: The Gut-Brain Connection
FFAR3 belongs to the gut-brain axis cluster. It responds to short-chain fatty acids such as propionate and butyrate, which gut microbes produce. It is found in gut hormone-producing cells and in the sympathetic nervous system, linking gut microbial activity to autonomic regulation. Research suggests that impaired FFAR3 signalling, especially alongside an imbalanced gut microbiome, may contribute to sympathetic-parasympathetic imbalance in post-COVID dysautonomia. Variants include rs2074058 and rs35595281.
Practical Implications
Learning about these genes can help you make sense of your experience, but it is important to keep the findings in perspective.
Genetics is one piece of a larger picture. Dysautonomia after COVID-19 likely reflects a mix of factors, including immune responses, infection history, fitness levels, other health conditions and environment. No single variant explains why someone develops POTS or other autonomic symptoms.
Patterns may matter more than single results. Looking at several genes along the same pathway, from norepinephrine production to recycling and receptor response, may offer a more meaningful view than any one variant alone.
Your results can support better conversations. Bringing genetic insights to a doctor, cardiologist or autonomic specialist may help frame questions about your symptoms. Only a qualified healthcare professional can properly assess your autonomic function, using tools such as standing tests or tilt-table testing.
Track your own patterns. Many people find it useful to keep notes on heart rate when lying versus standing, triggers such as heat or large meals, and how activity affects symptoms in the following days. This information, combined with any genetic insights, can help your care team understand your situation.
Avoid self-directed changes based on genes alone. Please do not change medications, start supplements or make significant lifestyle shifts based only on a DNA report. Any approach to managing dysautonomia should be discussed with a healthcare professional who knows your full history.
Get Personalized DNA Insights
If you already have raw data from a consumer DNA test, ChronicDNA can show you which variants you carry in genes linked to autonomic function, gut-brain signalling and Long COVID research. Your report is designed to be informational and to help you have more informed conversations with your healthcare team. Get your ChronicDNA report